CARSGEN-B(02171.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 66.66 million, loss narrowed by 11.52% YoY

NewTimeSpace News: August 18, 2026, CARSGEN-B(02171.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 61.92 million, increased by 21.5% YoY; Net Profit stood at loss of CNY 70.84 million, loss narrowed by 6.15% YoY; Profit Attributable to Shareholders stood at loss of CNY 66.66 million, loss narrowed by 11.52% YoY; Basic Earnings Per Share (EPS) stood at loss of CNY 0.13.

In terms of profitability, CARSGEN-B Gross Profit changed from CNY 29.37 million in the same period last year to CNY 42.02 million in the current period, increased by CNY 12.65 million; gross profit margin changed from 57.63% in the same period last year to 67.86% in the current period, increased by 10.23 percentage points; net profit changed from loss of CNY 75.48 million in the same period last year to loss of CNY 70.84 million in the current period, increased by CNY 4.64 million; net profit margin changed from -148.12% in the same period last year to -114.41% in the current period, increased by 33.71 percentage points.

In terms of earnings quality, CARSGEN-B Operating Profit changed from loss of CNY 76.7 million in the same period last year to loss of CNY 71.34 million in the current period, increased by CNY 5.37 million; Operating Profit Margin changed from -150.52% in the same period last year to -115.21% in the current period, increased by 35.3 percentage points.

In terms of financial soundness, CARSGEN-B Debt-to-Asset Ratio changed from 36.43% in the same period last year to 30.84% in the current period, decreased by 5.59 percentage points; Total Equity changed from CNY 962.133 million in the same period last year to CNY 1.092 billion in the current period, increased by CNY 130.3 million; Current Liabilities changed from CNY 213.8 million in the same period last year to CNY 206.14 million in the current period, decreased by CNY 7.66 million; Quick Ratio changed from 6.4 in the same period last year to 7.04 in the current period, increased by 0.64 percentage points.

In terms of R&D investment focus, CARSGEN-B R&D Expenses changed from CNY 130.22 million in the same period last year to CNY 132.46 million in the current period, increased by CNY 2.24 million; R&D to Total Revenue Ratio changed from 255.53% in the same period last year to 213.93% in the current period, decreased by 41.6 percentage points.

By the close of trading on August 18, 2026, CARSGEN-B(02171) saw a gain of 2.15% in its share price, closing at HKD 14.7. The full-day turnover stood at HKD 29.55 million, with the latest market capitalization at HKD 8.74 billion.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.